» Articles » PMID: 15333476

Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals with Type 2 Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2004 Aug 31
PMID 15333476
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study examines the association between oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes.

Research Design And Methods: Using administrative claims data (2000-2001) from a managed care organization in the Midwestern U.S., this study analyzed 900 enrollees, aged 18 years and over, with type 2 diabetes who were taking oral antihyperglycemic agents both years but who did not use insulin. Nonadherence was defined as a medication possession ratio (MPR) <80%. Multivariate logistic regression analyses were performed where hospitalization in 2001 was regressed on nonadherence to the oral antihyperglycemic drug regimen in 2000, while controlling for nonadherence to drugs for hypertension and dyslipidemia and for hospitalization in 2000, age, sex, intensity of the diabetes drug regimen, and comorbidities.

Results: The proportion of enrollees who were nonadherent to the antihyperglycemic drug regimen in 2001 was 28.9%, whereas 18.8 and 26.9% were nonadherent to antihypertensive and lipid-modifying drugs, respectively. The increase in the hospitalization rate for 2001 was most apparent where the antihyperglycemic MPR for 2000 dropped to <80%. Enrollees who were nonadherent to oral diabetes medications in 2000 were at higher risk of hospitalization in 2001 (odds ratio 2.53; 95% CI 1.38-4.64), whereas nonadherence to drugs for hypertension and dyslipidemia were not significantly associated with hospitalization.

Conclusions: Patients with type 2 diabetes who do not obtain at least 80% of their oral antihyperglycemic medications across 1 year are at a higher risk of hospitalization in the following year.

Citing Articles

Factors Associated with Antidiabetic Medications and Dietary Recommendation Adherence Among Patients with Type 2 Diabetes.

Dorvlo G, Kumah A, Ofosu S, Afakorzi S, Avorgbedor Y, Obot E Glob J Qual Saf Healthc. 2025; 8(1):3-14.

PMID: 39935716 PMC: 11808856. DOI: 10.36401/JQSH-23-52.


Regular HbA1c examination and health outcomes in adult patients with type 2 diabetes in South Korea: A retrospective cohort study.

Hong J, Kang H Medicine (Baltimore). 2024; 103(27):e38662.

PMID: 38968459 PMC: 11224849. DOI: 10.1097/MD.0000000000038662.


Persistence to Basal Insulin: Association With Health Outcomes in a Population With Type 2 Diabetes.

Nsiah I, Campbell P, Parikh M, Hines L, Pickering M, Nau D Clin Diabetes. 2024; 42(2):257-265.

PMID: 38694243 PMC: 11060632. DOI: 10.2337/cd23-0016.


Insurance barriers and inequalities in health care access: evidence from dual practice.

Goetjes E, Blankart K Health Econ Rev. 2024; 14(1):23.

PMID: 38512590 PMC: 10956272. DOI: 10.1186/s13561-024-00500-y.


Factors Associated With Improved A1C Values Among People Using High-Dose Insulin With Uncontrolled Type 2 Diabetes.

Hernandez W, Walter S, Popp R Clin Diabetes. 2024; 42(1):87-95.

PMID: 38230337 PMC: 10788650. DOI: 10.2337/cd23-0006.